← All companies

MANE

Veradermics, Incorporated

MANE NYSE Pharmaceutical Preparations EDGAR ↗

$101.89

-2.74 -2.62%

Key statistics

from XBRL data in SEC filings

Market cap

$4.26B

Revenue (TTM)

—

Net income (TTM)

-$70.0M

EPS (TTM)

$-111.91

P/E ratio

—

Dividend yield

—

Free cash flow

-$71.6M

Cash

$168M

Total assets

$397M

Gross margin

—

52-week range

$32.00 – $131.24

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Regulation FD disclosure; Other events Jul 15, 2026 10-Q Quarter ended 2026-03-31 May 12, 2026 8-K Results of operations (earnings release) May 12, 2026 8-K Entered a material agreement; Unregistered sale of equity May 1, 2026 8-K Results of operations (earnings release) Apr 27, 2026 8-K Regulation FD disclosure; Other events Apr 27, 2026 10-K Fiscal year ended 2025-12-31 Mar 30, 2026 8-K Results of operations (earnings release) Mar 30, 2026 8-K Amended charter or bylaws Feb 5, 2026

Other filings

SCHEDULE 13G/A May 15, 2026 D Item 06b May 15, 2026 SCHEDULE 13G May 7, 2026 SCHEDULE 13D/A May 5, 2026 4 May 5, 2026 SCHEDULE 13D/A May 5, 2026 SCHEDULE 13D May 5, 2026 3 FORM 3 May 5, 2026 424B4 424B3 Apr 30, 2026 FWP Apr 30, 2026 EFFECT Apr 29, 2026 S-1MEF Apr 29, 2026 FWP Apr 27, 2026 CORRESP Apr 27, 2026 CORRESP Apr 27, 2026 S-1 Apr 27, 2026 UPLOAD Apr 7, 2026 DRS Apr 6, 2026 4/A FORM 4/A Feb 27, 2026 SCHEDULE 13D Feb 12, 2026 SCHEDULE 13G Feb 12, 2026 SCHEDULE 13D Feb 11, 2026 SCHEDULE 13D Feb 11, 2026 4 Feb 9, 2026 3 Feb 9, 2026 4 Feb 5, 2026 4 FORM 4 Feb 5, 2026 4 FORM 4 Feb 5, 2026 4 FORM 4 Feb 5, 2026 4 FORM 4 Feb 5, 2026 4 FORM 4 Feb 5, 2026